Prognostic value and therapeutic potential of IAP family in head and neck squamous cell carcinoma

Xiaoqian Yu; Weiwei Cao; Xuejie Yang; Canping Yu; Wenying Jiang; Hongbin Guo; Xiaoyun He; Cheng Mei; Chunlin Ou

doi:doi:10.18632/aging.205551

← Back

Research Paper Volume 16, Issue 4 pp 3674—3693

Prognostic value and therapeutic potential of IAP family in head and neck squamous cell carcinoma

Figure 9. Association between IAP family members and immunotherapy efficacy. (A) Comparative analysis of the IAP family members levels in Riaz cohorts of anti-PD-1/CTLA-4 responders and non-responders. (B) Patients in the Riaz cohorts’ ROC curve for the IAP family.